Is MYND.CN undervalued or overvalued?
As of 2025-03-19, the Intrinsic Value of MYND Life Sciences Inc (MYND.CN) is -0.11 CAD. This MYND.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.09 CAD, the upside of MYND Life Sciences Inc is -224.44%. This means that MYND.CN is overvalued by 224.44%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
Range | Selected | Upside | |
a | |||
Fair Value | -0.11 - -0.11 | -0.11 | -224.44% |
DDM - Stable | 0.76 - 1.63 | 1.19 | 1301.3% |
DDM - Multi | 1.19 - 1.80 | 1.41 | 1560.9% |
Market Cap (mil) | 4.06 |
Beta | -3.59 |
Outstanding shares (mil) | 47.82 |
Enterprise Value (mil) | 7.06 |
Market risk premium | 5.10% |
Cost of Equity | 2.43% |
Cost of Debt | 5.00% |
WACC | 3.49% |